Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy
- 29 February 2004
- journal article
- Published by Elsevier in Pediatric Neurology
- Vol. 30 (2) , 102-106
- https://doi.org/10.1016/s0887-8994(03)00407-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Neurologic manifestations of tuberous sclerosis complexCurrent Neurology and Neuroscience Reports, 2002
- Cancer chemoresistance: The relationship between p53 and multidrug transportersInternational Journal of Cancer, 2002
- Tuberous sclerosis complex: a review of neurological aspectsEuropean Journal of Paediatric Neurology, 2002
- Multidrug resistance mediated by the ATP-binding cassette transporter protein MRPBioEssays, 1998
- Interaction between hamartin and tuberin, the TSC1 and TSC2 gene productsHuman Molecular Genetics, 1998
- Surgical management and seizure outcome in patients with tuberous sclerosisJournal of Neurosurgery, 1997
- Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.Proceedings of the National Academy of Sciences, 1996
- Suppression of the Neoplastic Phenotype by Replacement of theTsc2Gene in Eker Rat Renal Carcinoma CellsBiochemical and Biophysical Research Communications, 1996
- Identification and characterization of the tuberous sclerosis gene on chromosome 16Cell, 1993